Modulation of motor cortex excitability induced by pinch grip repetition A. GorslerS. ZittelJ. Liepert OriginalPaper 08 April 2004 Pages: 1005 - 1016
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment F. BlandiniM. CosentinoG. Nappi OriginalPaper 19 March 2004 Pages: 1017 - 1030
Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s disease G. ForteB. BoccaG. Sancesario OriginalPaper 19 March 2004 Pages: 1031 - 1040
Comparison of α-dihydroergocryptine and levodopa monotherapy in Parkinson’s disease: assessment of changes in DAT binding with [123I]IPT SPECT G. PöpperlK. TatschJ. Schwarz OriginalPaper 12 May 2004 Pages: 1041 - 1052
Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson’s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study M. OnofrjA. ThomasS. Markabi OriginalPaper 12 May 2004 Pages: 1053 - 1063
Presynaptic nigro-striatal function in a group of Alzheimer’s disease patients with parkinsonism: evidence from a dopamine transporter imaging study R. CeravoloD. VolterraniL. Murri OriginalPaper 18 June 2004 Pages: 1065 - 1073
Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias J. J. KelleyR. C. Roberts OriginalPaper 02 April 2004 Pages: 1075 - 1091
GSK-3β in cerebrospinal fluid of schizophrenia patients N. KozlovskyW. T. RegenoldG. Agam OriginalPaper 27 April 2004 Pages: 1093 - 1098